Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mexico and Chile head for healthcare agreement:

This article was originally published in Clinica

Executive Summary

The health ministers of Mexico and Chile have renewed their pledge to sign a healthcare agreement. During a recent meeting at the Mexican health service's headquarters in Mexico City, Dr Julio Frenk Mora and Dr Osvaldo Artaza Barrios expressed their aim of encouraging bilateral exchange of technical and scientific information and to promote joint projects in the field of healthcare management. Both countries are undergoing major healthcare reform: Chile's ambitious AUGE Plan appears to be succeeding despite strong opposition on economic grounds (see Clinica No 1020, p 13); the announcement of a Mexican healthcare plan is thought to be awaiting only political approval. The meeting comes a year after the two countries signed a statement of intent pledging to promote bilateral trade in areas affecting the healthcare industry (see Clinica No 972, p 10).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel